LJL. Jayasekara

L. Jayasekara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


L. Jayasekara has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of romosozumab on bone mineral density and fractures in postmenopausal women: a meta-analysis

    by M. Dilshani, L. Jayasekara, G. Liyanage, S. Lekamwasam

    Purpose: Romosozumab, a mono-clonal antibody has been approved for the treatment of postmenopausal women with osteoporosis and high fracture risk. This meta-analysis evaluated the effect of romosozumab on Bone Mineral Density (BMD) and fracture occurrence in postmenopausal women with osteoporosis.Methods: A systematic search was done adhered to the PRISMA guidelines in PubMed, Ovid and Clinicaltrials.gov and eligible studies were selected. The details related to study participants, changes in BMD at the lumber spine (LS), total hip (TH) and femoral neck (FN) and the occurrence of fractures during the period were extracted. The mean differences of BMDs between the two groups and odds ratios (OR) of fractures were considered as the outcome of the studies.Results: Of the 11 potentially eligible articles, only four studies fulfilled the selection criteria and they were included in the final analysis. Romosozumab therapy for 12 months increased mean BMD at the LS by 12.7% (95% CI, 9.7, 15.6), TH by 4.8% (95% CI, 3.3,6.3) and FN by 4.1% (95% CI, 3.1, 5.2). Treatment with romosozumab decreased the odds of new vertebral fractures and vertebral fractures by 58% (OR=0.42, CI, 0.23,0.91) and 25% (OR=0.75, CI, 0.53,1.06) respectively at the end of 12 months.Conclusion: Romosozumab significantly increases BMD at LS, TH and FN and reduces the risk of new vertebral and non-vertebral fractures in postmenopausal women with osteoporosis.


  • Open Access

    Variation in plant morphology and leaf essential oil composition of a representative Cinnamomum verum collection from Sri Lanka

    by M.R. Prathibhani, R. Azad, S. Ranaweera, L. Jayasekara, R.A.A.K. Ranawaka, G. Senanayake, S. Abeynayake, S. Geekiyanage

    Sri Lankan cinnamon germplasm is an underexploited genetic resource of high breeding potential. A representative collection of a cultivated cinnamon germplasm with 48 accessions, is established at the University of Ruhuna, Sri Lanka. From that collection, 40 three-year-old vegetative-propagated accessions, were used in this study to study the variations in plant morphology and leaf oil composition. Flush colour was determined as four main categories of pink, red, brown, and green in all 48 accessions. Leaf length, leaf width, leaf length to width ratio and petiole length varied from 7.9 to 14.5 cm, 3.8 to 7.3 cm, 1.8 to 3.07 cm, and 1 to 2.2 cm, respectively, in the selected 40 accessions. Both the good fragrant aroma category of bark fragrance and the sweet pungent category of bark taste were recorded in 21 of the 40 accessions. Twenty (20) accessions from above collection were selected for leaf oil analysis. Gas chromatography-mass spectrometry (GC-MS) of leaf oil revealed the presence of 146 chemical compounds. Eugenol was the major compound of 17 accessions (52.2% to 79.5%). Two accessions with zero eugenol contained 86.8% and 91.9% of benzyl benzoate (BB), in contrast to that of 0%-0.65% from other accessions. One accession produced 16.6% eugenol and 22.3% BB. A green flush colour associated with a higher BB percentage suggested a potential morphological marker for BB. The PCA for 20 accessions explained 88.11% of total variance. The cinnamon accessions with high BB, KA11 and GB17, were clustered together, and HB12 was isolated on a different cluster. Positive correlations were detected between linalool and β-caryophyllene (0.649), linalool and BB (0.770) (p < 0.01), and negative correlations between eugenol and linalool (-0.630) and eugenol and BB (-0.886) (p <0.01).